Authors:
MCKENNA CJ
BURKE SE
OPGENORTH TJ
PADLEY RJ
CAMRUD LDJ
CAMRUD AR
CARLSON PJ
LERMAN A
HOLMES DR
SCHWARTZ RS
Citation: Cj. Mckenna et al., SELECTIVE ETA-RECEPTOR ANTAGONISM REDUCES NEOINTIMAL HYPERPLASIA IN APORCINE CORONARY STENT MODEL, Journal of the American College of Cardiology, 31(2), 1998, pp. 144-144
Authors:
PADLEY RJ
MANSKI R
BOYLE P
ROBERTSON C
ROEHRBORN CG
Citation: Rj. Padley et al., A METAANALYSIS OF THE EFFECT OF TERAZOSIN VERSUS PLACEBO ON SYMPTOMS AND FLOW-RATE IN RANDOMIZED, PLACEBO-CONTROLLED TRIALS, The Journal of urology, 159(5), 1998, pp. 985-985
Authors:
MAURATH C
LIN T
HOSMANE B
JORDAN D
PADLEY RJ
Citation: C. Maurath et al., DOSE-RESPONSE OF ADVERSE EVENTS (AE) IN TITRATION STUDIES OF TERAZOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 2-2
Authors:
ROEHRBORN CG
OESTERLING JE
AUERBACH S
KAPLAN SA
LLOYD LK
MILAM DE
PADLEY RJ
Citation: Cg. Roehrborn et al., THE HYTRIN COMMUNITY ASSESSMENT TRIAL STUDY - A ONE-YEAR STUDY OF TERAZOSIN VERSUS PLACEBO IN THE TREATMENT OF MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA, Urology, 47(2), 1996, pp. 159-168
Authors:
HILLMAN AL
SCHWARTZ JS
WILLIAN MK
PESKIN E
ROEHRBORN CG
OESTERLING JE
MASON MF
MAURATH CJ
DEVERKA PA
PADLEY RJ
Citation: Al. Hillman et al., THE COST-EFFECTIVENESS OF TERAZOSIN AND PLACEBO IN THE TREATMENT OF MODERATE TO SEVERE BENIGN PROSTATIC HYPERPLASIA, Urology, 47(2), 1996, pp. 169-178
Authors:
LEPOR H
WILLIFORD WO
BARRY MJ
BRAWER MK
DIXON CM
GORMLEY G
HAAKENSON C
MACHI M
NARAYAN P
PADLEY RJ
Citation: H. Lepor et al., THE EFFICACY OF TERAZOSIN, FINASTERIDE, OR BOTH IN BENIGN PROSTATIC HYPERPLASIA, The New England journal of medicine, 335(8), 1996, pp. 533-539